Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


BeiGene, EUSA Pharma Unveil China's NMPA Approval Of SYLVANT For Idiopathic Multicentric Castleman Disease


RTTNews | Dec 3, 2021 12:40AM EST

00:40 Friday, December 3, 2021 (RTTNews) - BeiGene, EUSA Pharma Unveil China's NMPA Approval Of SYLVANT For Idiopathic Multicentric Castleman Disease

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC